K983501

Substantially Equivalent

ACCUSIGN DOA 10,ACCUSIGN DOA PANEL,ACCUSIGN MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP,BIOSIGN DOA 10, BIOSIGN MET/OPI/COC/

Applicant: Princeton BioMeditech Corp.
Product code: LAG
Advisory panel: Clinical Toxicology
Date received: 1998-10-06
Decision date: 1998-12-18
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Princeton, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.